{
  "abstract_id": "3291",
  "abstract_title": "Phase 2 trial of zilovertamab vedotin in combination with cyclophosphamide, doxorubicin, and prednisone plus rituximab in diffuse large B-cell lymphoma: Updated analysis of waveline-007",
  "pipeline_status": "success",
  "last_completed_step": "step5_consolidation",
  "failed_step": null,
  "error": null,
  "steps": {
    "step1_regimen": {
      "status": "success",
      "llm_calls": 5
    },
    "step2_extraction": {
      "status": "success",
      "llm_calls": 5
    },
    "step3_selection": {
      "status": "success",
      "llm_calls": 4
    },
    "step4_explicit": {
      "status": "success",
      "llm_calls": 1
    },
    "step5_consolidation": {
      "status": "success",
      "llm_calls": 0
    }
  },
  "total_llm_calls": 15,
  "last_updated": "2026-01-18T07:23:37.824022Z"
}